LC Fleischer, HT Spencer,
SS Raikar - Journal of hematology & oncology, 2019 - Springer
Chimeric antigen receptor (CAR) T cell therapy has been successful in treating B cell
malignancies in clinical trials; however, fewer studies have evaluated CAR T cell therapy for …